41
Participants
Start Date
April 17, 2020
Primary Completion Date
September 14, 2024
Study Completion Date
September 14, 2024
Ceftolozane/Tazobactam
"Participants 12 to \<18 years of age: IV ceftolozane 2 g with tazobactam 1 g infused over a 60-minute period.~Participants \<12 years of age: IV ceftolozane 40 mg/kg with tazobactam 20 mg/kg infused over a 60-minute period (not to exceed a dose of ceftolozane 2g and tazobactam 1 g)."
Montefiore Medical Center [Bronx, NY] ( Site 1313), New York
SA Tallinna Lastehaigla/Tallinn Children's Hospital ( Site 0201), Tallinn
West Virginia University ( Site 1310), Morgantown
AdventHealth Orlando ( Site 1318), Orlando
SI Dnipropetrovsk Regional Children Clinical Hospital DOR ( Site 1205), Dnipro
SA Tartu Ulikooli Kliinikum Lastekliinik ( Site 0200), Tartu
Children's Wisconsin ( Site 1321), Milwaukee
Mayo Clinic in Rochester, Minnesota ( Site 1322), Rochester
Sanford Children's Hospital ( Site 1301), Sioux Falls
Kharkiv City Children Hospital 16 ( Site 1200), Kharkiv
Ivano-Frankivsk Regional Children Clinical Hospital ( Site 1204), Ivano-Frankivsk
Morozovskaya Children City Clinical Hospital ( Site 0901), Moscow
St. Olga Children City Hospital ( Site 0906), Saint Petersburg
Smolensk Regional Clinical Hospital ( Site 0903), Smolensk
Oncomédica S.A.S ( Site 1506), Montería
Hospital Roberto del Río ( Site 1400), Santiago
Hospital General de Medellin ( Site 1503), Medellín
Ciensalud Ips S A S ( Site 1501), Barranquilla
Clinica de la Costa S.A.S. ( Site 1500), Barranquilla
Hippokration General Hospital of Thessaloniki ( Site 0400), Thessaloniki
Instituto Nacional de Pediatria-Unidad de Apoyo a la Investigación Clínica ( Site 1602), Mexico City
Hospital Infantil de Mexico Federico Gomez-Infectious Diseases ( Site 1600), Mexico City
Hospital Universitario Sant Joan de Deu ( Site 1100), Esplugues de Llobregat
Institution of Pediatr Obstetr and Gynec NAMS of Ukraine ( Site 1203), Kyiv
Merck Sharp & Dohme LLC
INDUSTRY